TREAT-NMD Conference

Leiden, Netherlands - December 2019

  • Welcome
  • Programme
    • Organizing Committee
  • Registration
    • Our Conference App
    • Poster abstract guidance
    • Posters – 10th December
    • Posters – 11th December
  • Venue
  • Accommodation
  • Our Sponsors
    • Sponsor us
    • Past Conferences
  • Visiting Leiden
    • Getting to Leiden

Markus Rüegg

Markus Rüegg is a biochemist by training and now Professor of Neurobiology at the Biozentrum of the University of Basel. His main research interests are the molecular pathways involved in muscle wasting diseases in general. He was a founding member of MyoContract Ltd, which later became Santhera Pharmaceuticals Ltd, and was a partner of TREAT-NMD. Markus is a member of scientific panels of Muscular Dystrophy UK and Cure CMD and he is chairman of the scientific council of the Swiss Foundation for Research on Muscle Diseases (FSRMM).

Connect and interact


To maximise your conference experience we have developed a smartphone app to help you not only find out about the conference but also make those all important  connections. We recommend you download the app onto your smartphone before attending our conference.

  - find out how -  


 

  • Welcome
  • Programme
  • Registration
  • Venue
  • Accommodation
  • Our Sponsors
  • Visiting Leiden

Copyright © 2021 · Privacy Policy · TREAT-NMD · Log in

This site uses cookies: Find out more.